BioMerieux EBITDA 2017-2023 | BMXMF
BioMerieux annual and quarterly EBITDA history from 2017 to 2023. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- BioMerieux EBITDA for the quarter ending December 31, 2023 was $M, a NAN% increase year-over-year.
- BioMerieux EBITDA for the twelve months ending December 31, 2023 was $0M, a NAN% increase year-over-year.
- BioMerieux 2023 annual EBITDA was $0.712B, a 15.28% decline from 2022.
- BioMerieux 2022 annual EBITDA was $0.84B, a 30.06% decline from 2021.
- BioMerieux 2021 annual EBITDA was $1.201B, a 37.68% increase from 2020.
| BioMerieux Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $712 |
| 2022 | $840 |
| 2021 | $1,201 |
| 2020 | $872 |
| 2019 | $627 |
| 2018 | $592 |
| 2017 | $515 |
| 2016 | $471 |
| 2015 | $ |
| BioMerieux Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-12-31 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.361B | $3.977B |
| bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $97.370B | 12.08 |
| Cencora (COR) | United States | $46.142B | 17.63 |
| ICON (ICLR) | Ireland | $23.387B | 21.01 |
| DiDi Global (DIDIY) | China | $22.455B | 0.00 |
| Avantor (AVTR) | United States | $16.248B | 24.64 |
| Natera (NTRA) | United States | $14.836B | 0.00 |
| Revvity (RVTY) | United States | $14.650B | 25.65 |
| Viatris (VTRS) | United States | $13.928B | 4.24 |
| CochLear (CHEOY) | Australia | $12.549B | 0.00 |
| Solventum (SOLV) | United States | $12.541B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.123B | 28.59 |
| Charles River Laboratories (CRL) | United States | $9.600B | 18.14 |
| Sonic Healthcare (SKHHY) | Australia | $8.566B | 0.00 |
| Doximity (DOCS) | United States | $7.827B | 49.60 |
| HealthEquity (HQY) | United States | $7.651B | 41.52 |
| Bausch + Lomb (BLCO) | Canada | $7.165B | 30.83 |
| PACS (PACS) | United States | $6.258B | 0.00 |
| Life Times (LTH) | United States | $5.174B | 43.25 |
| Organon (OGN) | United States | $4.467B | 4.54 |
| Sotera Health (SHC) | United States | $4.384B | 22.11 |
| Surgery Partners (SGRY) | United States | $4.016B | 44.49 |
| BrightSpring Health Services (BTSG) | United States | $2.762B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.761B | 0.00 |
| Concentras Parent (CON) | United States | $2.683B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.504B | 94.29 |
| Alignment Healthcare (ALHC) | United States | $2.058B | 0.00 |
| Premier (PINC) | United States | $2.005B | 9.01 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.922B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.557B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.543B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.456B | 25.60 |
| QDM (QDMI) | Hong Kong, SAR China | $1.370B | 35.88 |
| Establishment Labs Holdings (ESTA) | $1.262B | 0.00 | |
| CareDx (CDNA) | United States | $1.220B | 0.00 |
| Agilon Health (AGL) | United States | $1.160B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.108B | 12.06 |
| Embecta (EMBC) | United States | $0.818B | 5.45 |
| InnovAge Holding (INNV) | United States | $0.801B | 0.00 |
| SBC Medicals (SBC) | United States | $0.744B | 0.00 |
| Sharecare (SHCR) | United States | $0.532B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.436B | 0.00 |
| Enhabit (EHAB) | United States | $0.362B | 31.30 |
| DocGo (DCGO) | United States | $0.349B | 13.11 |
| Sera Prognostics (SERA) | United States | $0.236B | 0.00 |
| Biodesix (BDSX) | United States | $0.234B | 0.00 |
| Beauty Health (SKIN) | United States | $0.207B | 0.00 |
| ModivCare (MODV) | United States | $0.200B | 6.35 |
| Ascend Wellness Holdings (AAWH) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.190B | 0.00 |
| MultiPlan (MPLN) | United States | $0.178B | 0.00 |
| Nutex Health (NUTX) | United States | $0.126B | 0.00 |
| So-Young (SY) | China | $0.103B | 25.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.060B | 0.00 |
| OncoCyte (OCX) | United States | $0.052B | 0.00 |
| NeueHealth (NEUE) | United States | $0.046B | 1.83 |
| Co-Diagnostics (CODX) | United States | $0.041B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.035B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.026B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| XWELL (XWEL) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |